Article
Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer
18 Apr 2019
Abstract excerpt
Synergistic effects of BRAFV600E and TERT promoter mutations on the poor clinical outcomes in papillary thyroid cancer (PTC) have been demonstrated. The potential mechanism of this phenomenon has been proposed: MAPK pathway activation by the BRAFV600E mutation may upregulate E-twenty six (ETS) transcription factors, increasing TERT expression by binding to the ETS-binding site generated by the TERT promoter...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
